Peer Exchange

Advances in the Diagnosis and Management of Multiple Sclerosis

EPISODE 1 : Diagnosing MS in the Modern Era

Experts react to recent revisions to the McDonald criteria in multiple sclerosis and consider their impact on diagnosing the condition.

EPISODE 2 : Early Identification and Diagnosis of MS

Patient characteristics that now help physicians identify and diagnose multiple sclerosis earlier.

EPISODE 3 : Diagnostic Tools Used to Identify MS

Recommendations for spinal taps and MRI assessments to help diagnose multiple sclerosis.

EPISODE 4 : Surrogate Markers for MS

Surrogate markers being investigated and used to help physicians diagnose and manage patients with multiple sclerosis.

EPISODE 5 : Early Initiation of DMTs in MS

Recommendations for earlier initiation of disease-modifying therapy based on recent data in multiple sclerosis.

EPISODE 6 : Appropriateness for Induction Therapy in MS

Experts in the management of multiple sclerosis debate the appropriateness for early, aggressive induction therapy in patients.

EPISODE 7 : Newer Therapies in MS: Optimized Care

With new high efficacy therapies entering the field in multiple sclerosis, clinicians comment on strategies for optimally managing patients.

EPISODE 8 : Oral Cladribine Therapy for MS

Clinical overview of current phase 3 trials investigating oral cladribine for the treatment of patients with multiple sclerosis.

EPISODE 9 : Considerations for Using Oral Cladribine in MS

Reactions to the potential approval of oral cladribine in multiple sclerosis and considerations for potential treatment indications and sequencing.

EPISODE 10 : Recommendations for Restarting Therapy in MS

Considerations for restarting therapy in patients with multiple sclerosis and recommendations for investigating better targets to help clinicians make treatment decisions.

EPISODE 11 : Significance of Understanding MOAs When Treating MS

The significance of having a full understanding of a therapy’s mechanism of action when managing patients with multiple sclerosis in the clinic.

EPISODE 12 : Treatment Options for Progressive MS

Expert clinicians remark on the significance of the recent approval of ocrelizumab for primary progressive multiple sclerosis and discuss the potential of siponimod for secondary progressive MS.

EPISODE 13 : Options in the Pipeline for Progressive MS

Various treatment options under investigation for the treatment of progressive multiple sclerosis.